久久精品99中文字幕,αV日韩每日影视

2024 Global Top 10 Pharmaceutical Companies Market Trend The 2024 global ranking of the top 10 pharmaceutical companies showcases the continued strength of industry leaders like Johnson & Johnson, Roche, and Merck. Pfizer, AstraZeneca, and Eli Lilly also maintain strong positions with impressive growth and strategic investments.
The Global Vaccine Market: How Pfizer, Merck, GSK & Sanofi Maintain Their Dominance Market Trend As the pandemic subsides, the industry is returning to pre-pandemic dynamics, with Pfizer strengthening its pneumonia vaccine leadership, Merck betting on HPV and RSV, GSK focusing on meningitis, and Sanofi expanding its RSV monoclonal antibody business.
Top 16 Best-Selling New Drugs Worldwide in 2024 Market Trend Discover the top 16 best-selling new drugs of 2024, featuring innovative FIC and BIC molecules, breakthrough therapies across various fields, and products that stood out due to unique development strategies.
Top 10 Immunology Drugs to Watch in 2024 AbbVie Explore the top 10 best-selling immunology drugs of 2023, including Humira, Dupixent, Stelara, and more. Discover how these innovative therapies are shaping the market, driving clinical breakthroughs, and overcoming competitive challenges.
Teva Stock Soars 26%! Teva Pharmaceuticals Teva Pharmaceuticals' stock surged 26% after the TL1A antibody duvakitug demonstrated strong efficacy in treating ulcerative colitis (UC) and Crohn's disease (CD). The Phase 2b RELIEVE study showed promising results, with duvakitug outperforming existing treatments.
Capital Trend! $16.9 Billion Pharma Spin-off Sanofi Sanofi is negotiating the sale of a 50% stake in its consumer health unit Opella to Clayton, Dubilier & Rice for $16.9 billion. Learn more about the spin-off and other recent pharma industry trends.
Sanofi Accelerates Transformation Sanofi Sanofi accelerates its transformation into a biopharmaceutical company with strategic investments and the sale of its consumer health division. The article explores its latest moves in oncology, fibrosis, and RNA therapies, while navigating industry challenges.
Sanofi: Cutting Three Pipeline Programs Sanofi In Q3 2024, Sanofi reported a 15.7% increase in sales to €13.4 billion, driven by vaccine sales. The company removed three studies from its pipeline while achieving key regulatory approvals and positive trial results for several products, including Dupixent.
MNC Profiles: Who Values ??the Chinese Market Most? AstraZeneca Explore the competitive landscape of multinational pharmaceutical companies (MNCs) in China’s booming healthcare market. Delves into MNC revenue trends, strategies, and insights, highlighting which companies value the Chinese market most.
Sanofi's New Head of R&D: The Immunology Giant's Shift Sanofi Explore Sanofi's strategic transformation under new R&D head Houman Ashrafian. Following a significant market shift, Sanofi is refocusing on immunology, with 12 potential blockbuster drugs in the pipeline.

< Pre 123 Next >

Articles Archives

Hot Articles

All Categories

Agri & Industry Cosmetic Laboratory Pharmaceutical Food

国产91视频久久,亚洲综合色图在线观看,五月天操逼网,日韩色色AV,青青在线A片,亚洲最大色在线观看,欧美熟妇丝袜诱惑,青青操逼视频,日韩无码操出水